Cargando…
Using CRISPR/Cas9-Mediated GLA Gene Knockout as an In Vitro Drug Screening Model for Fabry Disease
The CRISPR/Cas9 Genome-editing system has revealed promising potential for generating gene mutation, deletion, and correction in human cells. Application of this powerful tool in Fabry disease (FD), however, still needs to be explored. Enzyme replacement therapy (ERT), a regular administration of re...
Autores principales: | Song, Hui-Yung, Chiang, Huai-Chih, Tseng, Wei-Lien, Wu, Ping, Chien, Chian-Shiu, Leu, Hsin-Bang, Yang, Yi-Ping, Wang, Mong-Lien, Jong, Yuh-Jyh, Chen, Chung-Hsuan, Yu, Wen-Chung, Chiou, Shih-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187889/ https://www.ncbi.nlm.nih.gov/pubmed/27983599 http://dx.doi.org/10.3390/ijms17122089 |
Ejemplares similares
-
Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy
por: Song, Hui-Yung, et al.
Publicado: (2019) -
Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation
por: Chien, Yueh, et al.
Publicado: (2016) -
Reversal of the Inflammatory Responses in Fabry Patient iPSC-Derived Cardiovascular Endothelial Cells by CRISPR/Cas9-Corrected Mutation
por: Song, Hui-Yung, et al.
Publicado: (2021) -
Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease
por: Kaneski, Christine R., et al.
Publicado: (2022) -
Functional evaluation of a novel GLA causative mutation in Fabry disease
por: Li, Ping, et al.
Publicado: (2019)